Five-year survival of patients with non-small cell lung cancer treated with alkalization therapy
Open Access
- 21 January 2026
- journal article
- Published by Elsevier in Translational Oncology
- Vol. 65, 102677
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- How protons pave the way to aggressive cancersNature Reviews Cancer, 2023
- Carga ácida de la dieta; mecanismos y evidencia de sus repercusiones en la saludNefrología, 2019
- Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohortLung Cancer, 2018
- Five-Year Survival in EGFR -Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIsJournal of Thoracic Oncology, 2016
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2016
- Otto Warburg's contributions to current concepts of cancer metabolismNature Reviews Cancer, 2011
- A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramerNature Structural & Molecular Biology, 2001
- Potential Renal Acid Load of Foods and its Influence on Urine pHJournal of the American Dietetic Association, 1995
- Increased pH and tumorigenicity of fibroblasts expressing a yeast proton pumpNature, 1988
- The growth factor-activatable Na+/H+ exchange system: a genetic approachTrends in Biochemical Sciences, 1985